degradation of a target messenger RNA through the incorporation of short interfering RNAs (siRNA) [1]. The application of siRNA based therapeutics is limited by the development of an effective delivery ... various…
presence of small interfering RNA (siRNA) in a cell leads to silencing of protein expression, offering the potential of a powerful therapeutic option for treatment of many conventionally intractable diseases…
neuroblastoma and carcinoma cells proliferation by suppression of proto-oncogene by small interfering RNA (siRNA) was studied. The proto-oncogene, MYC family participates in control of cell proliferation…
long period of treatment. Target-specific delivery and sustained release of anticancer agents and siRNA has attracted considerable research interest in cancer chemotherapy. It is clear that the single treatment…
degradation of a target messenger RNA through the incorporation of short interfering RNAs (siRNA) [1]. RNA interference (RNAi), the most popular biological tool by which double-stranded RNA (dsRNA) prompts ... study…
Microarray studies have shown that individual synthetic small interfering RNAs (siRNAs) can have substantial off-target effects. Pools of siRNAs, produced by incubation of dsRNAs with recombinant Dicer or RNase ... also…
Short interfering RNAs (siRNAs) can be used to suppress gene expression and have a lot of potential applications in therapy, yet how to design an effective siRNA is still under ... consideration. Numerous siRNA design…
Light-sensitive nanoparticles for siRNA and Paclitaxel co-delivery: They are catanionic vesicles that are formed spontaneously upon the interaction of an azobenzene-based cationic surfactant and a conventional anionic…
Hence, newer and targeted therapies are required. One of the ways is to explore siRNA therapy that works on RNA interference mechanism. siRNA of 21-25 nucleotide long help ... expression of cancerous gene by directing…
cells. The purpose of this study was to investigate the possibility of using CCT? siRNA sequences as anticancer agents by studying their ability to induce death of lung cancer cells ... lung epithelial cell lines were…
utilizing RNTs as a nanocarrier platform for the delivery of small interfering RNA (siRNA) to knockdown oncogenic genes to facilitate the elimination of cancer from the body. By conjugating positively ... surface of the…
Short interfering RNA (siRNA) has been widely used for studying gene functions in mammalian cells but varies markedly in its gene silencing efficacy. Although many design rules/guidelines for effective ... siRNAs based…
degradation of a target messenger RNA through the incorporation of short interfering RNAs (siRNA). The application of siRNA based therapeutics is limited by the development of an effective delivery system ... various…
generally resistant to chemotherapy. Paclitaxel has been selected as chemotherapeutic agent and siRNA that inhibits the BCL-2 oncogene has been selected as the genetic material. SLNs have been formulated ... order to…
approach. In this work, we have Insilico designed and evaluated the chemically synthesized potential siRNAs in HEK-293-T cell lines. The selected siRNAs were evaluated for cytotoxicity and antiviral ... using MTT assay…
efficient delivery of small RNA molecules like siRNAs or miRNAs still represents a major hurdle in their therapeutic application for gene knockdown or miRNA replacement. Polymeric nanoparticles e.g. based ... slice…
promising outcome. Due to the astonishing efforts in this field, more than 13 siRNA-based formulations are now being evaluated in clinical trials, more than 80 patents have been granted ... safe, effective, and…
Small interfering RNA (siRNA)-based technology is playing a pivotal role in understanding gene function. Huge siRNA libraries coupled to high-content screening are being applied to decipher molecular circuitries…
RNAi approach. The main objective of this work to evaluate the antiviral activity of siRNAs in cell culture. To design the siRNAs, we have selected orf1ab gene of MERS ... genome and used online software [2]. The…
Since the stability of siRNA molecules inside the blood and efficiency of siRNA distribution into target organs or tissues subsequent systemic management are the main issues that limit requests ... siRNA in human…
using an anti-cancer-like vaccine, delivered selectively to viral reservoirs. The use of siRNA’s to inactivate proteins that promote viral survival offer promising potential success in anti-retroviral
Since the stability of siRNA molecules in the blood and efficiency of siRNA delivery into target organs or tissues following systemic administration have been the major issues that limit applications ... siRNA in human…
Application of siRNA in high-throughput fashion is still in its early phase although the principle has been established for three years. In this review, we outline the different vector ... based siRNA delivery platforms…
lthough small interfering RNA (siRNA) treatment holds great promise for the treatment of cancers, the field has been held back by the availability of suitable delivery system. Unmodified, naked siRNAs ... endonuclease…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.